Detalles de la búsqueda
1.
90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.
Proc Natl Acad Sci U S A
; 112(42): 13045-50, 2015 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26438866
2.
A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase.
Gastroenterology
; 149(1): 67-78, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25865046
3.
18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.
J Infect Dis
; 212(8): 1250-60, 2015 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25828248
4.
Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction.
Proc Natl Acad Sci U S A
; 109(47): 19403-7, 2012 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23129637
5.
18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST).
Pediatr Blood Cancer
; 60(1): 59-64, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22645095
6.
90Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma.
Cancer Biother Radiopharm
; 35(4): 249-261, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32275165
7.
Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO).
Clin Endocrinol (Oxf)
; 71(1): 11-7, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19138315
8.
18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative Syndrome.
Clin Nucl Med
; 44(12): 949-955, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31689275
9.
Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
Endocr Relat Cancer
; 15(1): 311-23, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18310297
10.
Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma.
J Nucl Med
; 49(10): 1613-9, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18794260
11.
Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the "glucose-corrected" SUV.
Nucl Med Biol
; 35(4): 441-5, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18482681
12.
Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma.
J Nucl Med
; 48(7): 1077-83, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17574980
13.
Usefulness of standardized uptake values for distinguishing adrenal glands with pheochromocytoma from normal adrenal glands by use of 6-18F-fluorodopamine PET.
J Nucl Med
; 48(12): 1940-4, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18006611
14.
The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.
J Nucl Med
; 48(10): 1599-606, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17873132
15.
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation.
AIDS
; 20(7): 985-93, 2006 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-16603850
16.
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation.
AIDS
; 20(4): 495-503, 2006 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-16470113
17.
Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites.
Nucl Med Commun
; 27(1): 31-6, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16340721
18.
Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor.
J Clin Oncol
; 22(15): 3080-90, 2004 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15284258
19.
The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome.
J Clin Endocrinol Metab
; 89(5): 2214-21, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15126544
20.
Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma.
J Clin Endocrinol Metab
; 88(9): 4083-7, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12970267